Sudden Cardiac Death Number One Risk For Patients On Dialysis
Main Category: Cardiovascular / CardiologyAlso Included In: Urology / Nephrology; Clinical Trials / Drug Trials
Article Date: 23 Oct 2008 - 0:00 PDT
| Patient / Public: | ![]() |
|
| Healthcare Prof: | ![]() |
4 (1 votes) |
In a 10-year study of more than a thousand kidney failure patients, sudden cardiac death emerged as the number one cause of death for patients on dialysis, according to a Johns Hopkins researcher. The study, already published online and appearing in the Nov. 2 issue of Kidney International, identified systemic inflammatory response and malnutrition as key risk factors for the fatal heart attacks.
"This is believed to be the first time anyone has taken a rigorous prospective look at why so many patients on dialysis die from sudden cardiac death, and the results could help doctors identify those at highest risk and potentially save lives," says Rulan S. Parekh, M.D., associate professor in the Department of Nephrology at the Johns Hopkins University School of Medicine.
Parekh and her team gathered their data from the Choices for Healthy Outcomes In Caring for ESRD (CHOICE) cohort of 1,041 end-stage renal disease (ESRD) patients on dialysis. In a 9.5-year period, 658 of this group died. The largest number of these deaths, 146, were the result of sudden cardiac death (SCD), in this case unexpected deaths that occurred outside of the hospital setting.
The researchers then looked at previously recorded blood test results from 122 of these 146 SCD patients to search for a possible relationship between the deaths and levels of high-sensitivity C-reactive (hsCRP), interlukin-6 (IL-6) and albumin. The proteins IL-6 and hsCRP are both markers for widespread blood vessel and organ inflammation, while low albumin levels are associated with malnutrition.
Results showed that patients with high levels of either hsCRP or IL-6 were twice as likely to die from SCD as those with low levels of these proteins. Low albumin levels were associated with a 1.35 times increase in the risk of dying of SCD when compared with high levels, according to Parekh. In addition, those with low levels of albumin and high levels of hsCRP were four times more likely to die of SCD than those with high levels and albumin and low levels of hsCRP.
"These results tell us that ESRD patients with low albumin and/or high levels of IL-6 and hsCRP are at a significantly higher risk of SCD," says Parekh.
The half-million people in the United States with ESRD are 10 to 100 times more likely than the general public to die from cardiovascular disease, depending on age, according to Parekh. They have an annual mortality rate of over 20 percent, and one-fifth of these deaths are attributed to SCD.
Systemic inflammatory response is common with ESRD patients and occurs when the body responds to an infectious or noninfectious attack. Parekh says those with kidney failure are quite ill, and the chance of infection and chronic inflammation is higher. Malnutrition is also common with ESRD patients from the stress of kidney failure, loss of appetite and a highly restricted diet. Compounding the issue, she says, is that Medicare does not cover oral nutritional supplements.
"When people think of heart attacks, they think of cholesterol and obesity," Parekh says, "but these are risk factors for hardening of the arteries and are not directly linked to sudden heart death among patients on dialysis."
Other researchers from Johns Hopkins who contributed to this study include Neil R. Powe, M.D., M.P.H.; Josef Coresh, M.D., Ph.D.; Lucy A. Meoni, Sc.M.; Bernard G. Jaar, M.P.H and Nancy E. Fink of the Johns Hopkins University School of Medicine and Michael J. Klag, M.D., M.P.H.; W.H. Linda Kao, Ph.D. and Laura C. Plantinga, M.S. of the Bloomberg School of Public Health.
Johns Hopkins Medicine
901 S Bond St., Ste. 550
Baltimore, MD 21231
United States
http://www.hopkinsmedicine.org
Visit our cardiovascular / cardiology section for the latest news on this subject.
MLA
13 Feb. 2012. <http://www.medicalnewstoday.com/releases/126465.php>
APA
http://www.medicalnewstoday.com/releases/126465.php.
Please note: If no author information is provided, the source is cited instead.
|
Rate this article: (Hover over the stars then click to rate) |
Patient / Public: |
or |
Health Professional: |
Add Your Opinion
Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
![]()
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.





